Received 31 January 2013
aGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, People's Republic of China, and bTianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, People's Republic of China
Correspondence e-mail: firstname.lastname@example.org
The asymmetric unit of the title compound, C17H14BrCl3O, contains two independent molecules with different dihedral angles between the benzene rings [79.2 (1) and 72.7 (1)°]. In the crystal, weak C-H interactions link molecules related by translation along the b axis into two crystallographically independent chains.
For background to sodium-glucose cotransporter 2 (SGLT2) inhibitors, see: Washburn (2009); Meng et al. (2008). For the crystal structures of related cyclopropane derivatives, see: DeLacy & Kennard (1972); Lauher & Ibers (1975).
Data collection: CrystalClear (Rigaku/MSC, 2009); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: CV5386 ).
DeLacy, T. P. & Kennard, C. H. L. (1972). J. Chem. Soc. Perkin Trans. 2, pp. 2141-2147.
Lauher, J. W. & Ibers, J. A. (1975). J. Am. Chem. Soc. 97, 561-567.
Meng, M., et al. (2008). J. Med. Chem. 51, 1145-1149.
Rigaku/MSC (2009). CrystalClear-SM Expert and CrystalStructure. Rigaku/MSC, The Woodlands, Texas, USA.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Washburn, W. N. (2009). J. Med. Chem. 52, 1785-1794.